192 related articles for article (PubMed ID: 17224058)
1. Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure.
Gruhn B; Seidel J; Zintl F; Varon R; Tönnies H; Neitzel H; Bechtold A; Hoehn H; Schindler D
Orphanet J Rare Dis; 2007 Jan; 2():5. PubMed ID: 17224058
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in a family with DNA ligase IV deficiency syndrome.
Unal S; Cerosaletti K; Uckan-Cetinkaya D; Cetin M; Gumruk F
Pediatr Blood Cancer; 2009 Sep; 53(3):482-4. PubMed ID: 19418549
[TBL] [Abstract][Full Text] [Related]
3. Extreme growth failure is a common presentation of ligase IV deficiency.
Murray JE; Bicknell LS; Yigit G; Duker AL; van Kogelenberg M; Haghayegh S; Wieczorek D; Kayserili H; Albert MH; Wise CA; Brandon J; Kleefstra T; Warris A; van der Flier M; Bamforth JS; Doonanco K; Adès L; Ma A; Field M; Johnson D; Shackley F; Firth H; Woods CG; Nürnberg P; Gatti RA; Hurles M; Bober MB; Wollnik B; Jackson AP
Hum Mutat; 2014 Jan; 35(1):76-85. PubMed ID: 24123394
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature.
Schober S; Schilbach K; Doering M; Cabanillas Stanchi KM; Holzer U; Kasteleiner P; Schittenhelm J; Schaefer JF; Mueller I; Lang P; Handgretinger R
BMC Pediatr; 2019 Oct; 19(1):346. PubMed ID: 31604460
[TBL] [Abstract][Full Text] [Related]
5. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
Slack J; Albert MH; Balashov D; Belohradsky BH; Bertaina A; Bleesing J; Booth C; Buechner J; Buckley RH; Ouachée-Chardin M; Deripapa E; Drabko K; Eapen M; Feuchtinger T; Finocchi A; Gaspar HB; Ghosh S; Gillio A; Gonzalez-Granado LI; Grunebaum E; Güngör T; Heilmann C; Helminen M; Higuchi K; Imai K; Kalwak K; Kanazawa N; Karasu G; Kucuk ZY; Laberko A; Lange A; Mahlaoui N; Meisel R; Moshous D; Muramatsu H; Parikh S; Pasic S; Schmid I; Schuetz C; Schulz A; Schultz KR; Shaw PJ; Slatter MA; Sykora KW; Tamura S; Taskinen M; Wawer A; Wolska-Kuśnierz B; Cowan MJ; Fischer A; Gennery AR; ; ; ;
J Allergy Clin Immunol; 2018 Jan; 141(1):322-328.e10. PubMed ID: 28392333
[TBL] [Abstract][Full Text] [Related]
6. A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome.
Ben-Omran TI; Cerosaletti K; Concannon P; Weitzman S; Nezarati MM
Am J Med Genet A; 2005 Sep; 137A(3):283-7. PubMed ID: 16088910
[TBL] [Abstract][Full Text] [Related]
7. Ligase IV syndrome.
Chistiakov DA
Adv Exp Med Biol; 2010; 685():175-85. PubMed ID: 20687505
[TBL] [Abstract][Full Text] [Related]
8. Nijmegen breakage syndrome (NBS).
Chrzanowska KH; Gregorek H; Dembowska-Bagińska B; Kalina MA; Digweed M
Orphanet J Rare Dis; 2012 Feb; 7():13. PubMed ID: 22373003
[TBL] [Abstract][Full Text] [Related]
9. Ligase IV syndrome.
Chistiakov DA; Voronova NV; Chistiakov AP
Eur J Med Genet; 2009; 52(6):373-8. PubMed ID: 19467349
[TBL] [Abstract][Full Text] [Related]
10. [LIG4 syndrome: a report of four cases and literature review].
Yue T; Li JG; Zhou ZX; Hou J; Xu YJ; Liu R; Shi XD
Zhonghua Er Ke Za Zhi; 2019 Mar; 57(3):217-221. PubMed ID: 30818900
[No Abstract] [Full Text] [Related]
11. Novel compound heterozygous DNA ligase IV mutations in an adolescent with a slowly-progressing radiosensitive-severe combined immunodeficiency.
Tamura S; Higuchi K; Tamaki M; Inoue C; Awazawa R; Mitsuki N; Nakazawa Y; Mishima H; Takahashi K; Kondo O; Imai K; Morio T; Ohara O; Ogi T; Furukawa F; Inoue M; Yoshiura K; Kanazawa N
Clin Immunol; 2015 Oct; 160(2):255-60. PubMed ID: 26172957
[TBL] [Abstract][Full Text] [Related]
12. Ligase IV syndrome can present with microcephaly and radial ray anomalies similar to Fanconi anaemia plus fatal kidney malformations.
Madhu R; Beaman GM; Chandler KE; O'Sullivan J; Urquhart JE; Khan N; Martindale E; Briggs TA; Clayton-Smith J; Higgs J; Batra G; Kerr B; Woolf AS; Newman WG
Eur J Med Genet; 2020 Sep; 63(9):103974. PubMed ID: 32534991
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation corrects ligase IV deficiency.
He J; Tian X; Luo T; Zou R; Yin Z; Chen K; Zhu C; He X
Transpl Immunol; 2023 Oct; 80():101897. PubMed ID: 37437665
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation for inherited bone marrow failure syndromes.
Mehta P; Locatelli F; Stary J; Smith FO
Pediatr Clin North Am; 2010 Feb; 57(1):147-70. PubMed ID: 20307716
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing revealed DNA ligase IV deficiency in a "developmentally normal" patient with massive brain Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Sharapova SO; Chang EY; Guryanova IE; Proleskovskaya IV; Fedorova AS; Rutskaya EA; Aleinikova OV
Clin Immunol; 2016 Feb; 163():108-10. PubMed ID: 26774591
[TBL] [Abstract][Full Text] [Related]
16. CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair.
O'Driscoll M; Jeggo PA
Bone Marrow Transplant; 2008 Jun; 41(11):983-9. PubMed ID: 18278071
[TBL] [Abstract][Full Text] [Related]
17. Molecular and immunological characterization of DNA ligase IV deficiency.
Jiang J; Tang W; An Y; Tang M; Wu J; Qin T; Zhao X
Clin Immunol; 2016 Feb; 163():75-83. PubMed ID: 26762768
[TBL] [Abstract][Full Text] [Related]
18. Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.
Marsh RA; Rao MB; Gefen A; Bellman D; Mehta PA; Khandelwal P; Chandra S; Jodele S; Myers KC; Grimley M; Dandoy C; El-Bietar J; Kumar AR; Leemhuis T; Zhang K; Bleesing JJ; Jordan MB; Filipovich AH; Davies SM
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1460-70. PubMed ID: 25865646
[TBL] [Abstract][Full Text] [Related]
19. Two hits in one: whole genome sequencing unveils LIG4 syndrome and urofacial syndrome in a case report of a child with complex phenotype.
Fadda A; Butt F; Tomei S; Deola S; Lo B; Robay A; Al-Shakaki A; Al-Hajri N; Crystal R; Kambouris M; Wang E; Marincola FM; Fakhro KA; Cugno C
BMC Med Genet; 2016 Nov; 17(1):84. PubMed ID: 27855655
[TBL] [Abstract][Full Text] [Related]
20. Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey.
Kuşkonmaz B; Ünal Ş; Bayhan T; Aytaç Eyüboğlu S; Tavil B; Çetin M; Gümrük F; Uçkan Çetinkaya D
Pediatr Blood Cancer; 2016 Apr; 63(4):695-700. PubMed ID: 26703084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
